Cargando…

Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis

BACKGROUND: Hypertriglyceridemia (HTG) is a well-established cause of acute pancreatitis often leading to significant morbidity, mortality, and healthcare burden. This study aimed to describe the rate, reasons, and predictors of HTG-induced acute pancreatitis (HTG-AP) in the USA. METHODS: This retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kichloo, Asim, El-amir, Zain, Aucar, Maria, Dahiya, Dushyant Singh, Al-Haddad, Mohammad, Pisipati, Sailaja, Beiz, Hassan, Singh, Gurdeep, Gandhi, Darshan, Singh, Jagmeet, Pathappillil, Patrick, Mohideen, Haseeb, Shaka, Hafeez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913020/
https://www.ncbi.nlm.nih.gov/pubmed/35369677
http://dx.doi.org/10.14740/gr1484
_version_ 1784667315717013504
author Kichloo, Asim
El-amir, Zain
Aucar, Maria
Dahiya, Dushyant Singh
Al-Haddad, Mohammad
Pisipati, Sailaja
Beiz, Hassan
Singh, Gurdeep
Gandhi, Darshan
Singh, Jagmeet
Pathappillil, Patrick
Mohideen, Haseeb
Shaka, Hafeez
author_facet Kichloo, Asim
El-amir, Zain
Aucar, Maria
Dahiya, Dushyant Singh
Al-Haddad, Mohammad
Pisipati, Sailaja
Beiz, Hassan
Singh, Gurdeep
Gandhi, Darshan
Singh, Jagmeet
Pathappillil, Patrick
Mohideen, Haseeb
Shaka, Hafeez
author_sort Kichloo, Asim
collection PubMed
description BACKGROUND: Hypertriglyceridemia (HTG) is a well-established cause of acute pancreatitis often leading to significant morbidity, mortality, and healthcare burden. This study aimed to describe the rate, reasons, and predictors of HTG-induced acute pancreatitis (HTG-AP) in the USA. METHODS: This retrospective study analyzed the Nationwide Readmissions Database (NRD) for 2018 to determine all adults (≥ 18 years) readmitted within 30 days of an index hospitalization of HTG-AP. Hospitalization characteristics and adverse outcomes for 30-day readmissions were highlighted and compared with index admissions of HTG-AP. Furthermore, independent predictors for 30-day readmissions of HTG-AP were also identified. P values ≤ 0.05 were considered statistically significant. RESULTS: In 2018, the rate of 30-day readmission of HTG-AP was noted to be 13.5%. At the time of readmission, AP (45.2%) was identified as the most common principal diagnosis, followed by chronic pancreatitis (6.3%) and unspecified sepsis (4.8%). Compared to index admissions, 30-day readmissions of HTG-AP had a higher proportion of patients with Charlson Comorbidity Index (CCI) scores ≥ 3 (48.5% vs. 33.8%, P < 0.001). Furthermore, we noted higher rates of inpatient mortality (1.7% vs. 0.7%, odds ratio (OR): 2.55, 95% confidence interval (CI): 1.83 - 3.57, P < 0.001), mean length of stay (LOS) (5.6 vs. 4.1 days, OR: 1.5, 95% CI: 1.2 - 1.7, P < 0.001), and mean total healthcare charge (THC) ($56,799 vs. $36,078, OR: 18,702, 95% CI: 15,136 - 22,267, P < 0.001) for 30-day readmissions of HTG-AP compared to index admissions. Independent predictors for 30-day all-cause readmissions of HTG-AP included hypertension, protein energy malnutrition (PEM), CCI scores ≥ 3, chronic kidney disease and discharge against medical advice. CONCLUSIONS: AP was the principal diagnosis on presentation in only 45.2% patients for 30-day readmissions of HTG-AP. Compared to index admissions, 30-day readmissions of HTG-AP had a higher comorbidity burden, inpatient mortality, mean LOS and mean THC.
format Online
Article
Text
id pubmed-8913020
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-89130202022-03-31 Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis Kichloo, Asim El-amir, Zain Aucar, Maria Dahiya, Dushyant Singh Al-Haddad, Mohammad Pisipati, Sailaja Beiz, Hassan Singh, Gurdeep Gandhi, Darshan Singh, Jagmeet Pathappillil, Patrick Mohideen, Haseeb Shaka, Hafeez Gastroenterology Res Original Article BACKGROUND: Hypertriglyceridemia (HTG) is a well-established cause of acute pancreatitis often leading to significant morbidity, mortality, and healthcare burden. This study aimed to describe the rate, reasons, and predictors of HTG-induced acute pancreatitis (HTG-AP) in the USA. METHODS: This retrospective study analyzed the Nationwide Readmissions Database (NRD) for 2018 to determine all adults (≥ 18 years) readmitted within 30 days of an index hospitalization of HTG-AP. Hospitalization characteristics and adverse outcomes for 30-day readmissions were highlighted and compared with index admissions of HTG-AP. Furthermore, independent predictors for 30-day readmissions of HTG-AP were also identified. P values ≤ 0.05 were considered statistically significant. RESULTS: In 2018, the rate of 30-day readmission of HTG-AP was noted to be 13.5%. At the time of readmission, AP (45.2%) was identified as the most common principal diagnosis, followed by chronic pancreatitis (6.3%) and unspecified sepsis (4.8%). Compared to index admissions, 30-day readmissions of HTG-AP had a higher proportion of patients with Charlson Comorbidity Index (CCI) scores ≥ 3 (48.5% vs. 33.8%, P < 0.001). Furthermore, we noted higher rates of inpatient mortality (1.7% vs. 0.7%, odds ratio (OR): 2.55, 95% confidence interval (CI): 1.83 - 3.57, P < 0.001), mean length of stay (LOS) (5.6 vs. 4.1 days, OR: 1.5, 95% CI: 1.2 - 1.7, P < 0.001), and mean total healthcare charge (THC) ($56,799 vs. $36,078, OR: 18,702, 95% CI: 15,136 - 22,267, P < 0.001) for 30-day readmissions of HTG-AP compared to index admissions. Independent predictors for 30-day all-cause readmissions of HTG-AP included hypertension, protein energy malnutrition (PEM), CCI scores ≥ 3, chronic kidney disease and discharge against medical advice. CONCLUSIONS: AP was the principal diagnosis on presentation in only 45.2% patients for 30-day readmissions of HTG-AP. Compared to index admissions, 30-day readmissions of HTG-AP had a higher comorbidity burden, inpatient mortality, mean LOS and mean THC. Elmer Press 2022-02 2022-01-10 /pmc/articles/PMC8913020/ /pubmed/35369677 http://dx.doi.org/10.14740/gr1484 Text en Copyright 2022, Kichloo et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kichloo, Asim
El-amir, Zain
Aucar, Maria
Dahiya, Dushyant Singh
Al-Haddad, Mohammad
Pisipati, Sailaja
Beiz, Hassan
Singh, Gurdeep
Gandhi, Darshan
Singh, Jagmeet
Pathappillil, Patrick
Mohideen, Haseeb
Shaka, Hafeez
Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis
title Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis
title_full Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis
title_fullStr Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis
title_full_unstemmed Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis
title_short Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis
title_sort clinical outcomes and predictors of thirty-day readmissions of hypertriglyceridemia-induced acute pancreatitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913020/
https://www.ncbi.nlm.nih.gov/pubmed/35369677
http://dx.doi.org/10.14740/gr1484
work_keys_str_mv AT kichlooasim clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT elamirzain clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT aucarmaria clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT dahiyadushyantsingh clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT alhaddadmohammad clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT pisipatisailaja clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT beizhassan clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT singhgurdeep clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT gandhidarshan clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT singhjagmeet clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT pathappillilpatrick clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT mohideenhaseeb clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis
AT shakahafeez clinicaloutcomesandpredictorsofthirtydayreadmissionsofhypertriglyceridemiainducedacutepancreatitis